Shares of Lupin gained 4% on Thursday after the Indian drugmaker announced that it would construct a manufacturing plant in Coral Springs, Florida, one of its largest U.S. investments. The 5-acre, 70,000-square-foot facility will result in total spending of $250 million over five years in research, infrastructure, and capital investment.